Subjects: H.R.1188 — 113th Congress (2013-2014)

  • Competition and antitrust
  • Congressional oversight
  • Contracts and agency
  • Drug therapy
  • Government studies and investigations
  • Health
  • Health care costs and insurance
  • Health facilities and institutions
  • Prescription drugs
  • Retail and wholesale trades